Guided Pathway

New to Genomic Testing in Nephrology

Here's a summary for this feature

Summary

Genomic testing is a powerful diagnostic tool for identifying the genetic cause of kidney disease — but the pathway from clinical suspicion to a funded test can feel complex for first-time orderers. This guided pathway walks you through every stage, from assessing patient suitability, conducting a nephrology workup, and selecting the appropriate gene panel under MBS items 73401, 73402, or 73298, through to obtaining consent, submitting samples, and managing results. The pathway branches based on your patient's presentation, including whether the case suits mainstream testing, requires Renal Genetics MDT support, or needs referral to a clinical genetics service. Nephrologists who are already familiar with the testing process and are ready to order can use one of the Checklist pathways instead for a quicker reference.

Curated by Erin Lynch

Last updated 18 June 2026